Compounds > conivaptan
Page last updated: 2024-09-04

conivaptan and mci 9038

conivaptan has been researched along with mci 9038 in 2 studies

Compound Research Comparison

Studies
(conivaptan)		Trials
(conivaptan)		Recent Studies (post-2010)
(conivaptan)		Studies
(mci 9038)		Trials
(mci 9038)		Recent Studies (post-2010) (mci 9038)
18817641,08783349

Protein Interaction Comparison

ProteinTaxonomyconivaptan (IC50)mci 9038 (IC50)
ProthrombinHomo sapiens (human)0.22

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for conivaptan and mci 9038

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for conivaptan and mci 9038

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008